• 1
    Jones R, Galmiche JP. What do we mean by GERD? Definition and diagnosis. Aliment Pharmacol Ther 2005; 22 (Suppl. 1): 210.
  • 2
    Dent J, Armstrong D, Delaney B, et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53 (Suppl. 4): iv 124.
  • 3
    Locke GR, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 6429.
  • 4
    Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, et al. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004; 19: 95105.
  • 5
    Bretagne JF, Richard-Molard B, Honnorat C, et al. Gastro-esophageal reflux disease in the French population: results of an observational survey performed in a sample of nearly 8000 subjects of 18 years of age and above. Gastroenterology 2004; 126: A311.
  • 6
    Garrow JS, Webster J. Quetelet's Index (W/H2) as a measure of fatness. Int J Obes 1985; 9: 14753.
  • 7
    Moayeddi P, Axon ATR. Gastro-oesophageal reflux disease – the extent of the problem. Aliment Pharmacol Ther 2005; 22 (Suppl. 1): 119.
  • 8
    Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 144856.
  • 9
    Louis E, DeLooze D, Deprez P, et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 2002; 14: 27984.
  • 10
    Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004; 22: 10814.
  • 11
    ObEpi. L'obésité et le surpoids en France 2003. Available at: Last accessed 1 January 2006.
  • 12
    El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005; 100: 124350.
    Direct Link:
  • 13
    Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 158994.
  • 14
    Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995; 27: 6770.
  • 15
    Rey E, Moreno-Elola-Olaso C, Rodriguez-Artalejo F, Diaz-Rubio M. Medical consultation for gastro-oesophageal reflux symptoms: reasons and associated factors. Digestion 2004; 70: 1737.
  • 16
    Nandurkar S, Locke R, Murray JA, et al. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 2005; 100: 145965.
    Direct Link:
  • 17
    Bretagne JF, Rey JF, Caekaert A, Barthélemy P. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study. Dig Liver Dis 2005; 37: 56670.
  • 18
    McColl E, Junghard O, Wiklund I, et al. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians’ assessments agree with those of their patients? Am J Gastroenterol 2005; 100: 118.
    Direct Link:
  • 19
    Fallone CA, Guyatt GH, Armstrong D, et al. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004; 20: 11619.